This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
ISRG vs. MDT: Which Robotic Surgery Stock Is a Smarter Buy Now?
by Indrajit Bandyopadhyay
Intuitive Surgical or Medtronic -- who leads the future of robotic surgery? Here's a comparative analysis to help you make a smart choice for 2025.
Intuitive Surgical, Inc. (ISRG) is Attracting Investor Attention: Here is What You Should Know
by Zacks Equity Research
Recently, Zacks.com users have been paying close attention to Intuitive Surgical (ISRG). This makes it worthwhile to examine what the stock has in store.
Intuitive Surgical, Inc. (ISRG) Stock Moves -0.58%: What You Should Know
by Zacks Equity Research
Intuitive Surgical, Inc. (ISRG) closed at $539.54 in the latest trading session, marking a -0.58% move from the prior day.
Why Is Penumbra (PEN) Down 10.6% Since Last Earnings Report?
by Zacks Equity Research
Penumbra (PEN) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
ISRG Stock Gains More than 8% YTD: Will the Uptrend Continue?
by Indrajit Bandyopadhyay
Intuitive Surgical's shares seem to recover after declining more than 30% in nearly two months. Is it the right time to invest?
Intuitive Surgical, Inc. (ISRG) Is a Trending Stock: Facts to Know Before Betting on It
by Zacks Equity Research
Zacks.com users have recently been watching Intuitive Surgical (ISRG) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
The Transformative Rise of Global Robotics: A 2025 Market Analysis
by Vasundhara Sawalka
Robotics is poised for robust growth in 2025. Watch NVDA, ISRG, SERV and PATH for potential market dominance across healthcare, manufacturing and mobility sectors.
ISRG vs. SYK: Which Robotic-Device Innovator Is a Better Buy?
by Indrajit Bandyopadhyay
Both are leaders in robotic-assisted surgery ??? Intuitive Surgical in soft tissue procedures and Stryker in orthopedic surgeries. Which company is a better bet now?
Intuitive Surgical, Inc. (ISRG) is Attracting Investor Attention: Here is What You Should Know
by Zacks Equity Research
Zacks.com users have recently been watching Intuitive Surgical (ISRG) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
ISRG Stock Falls Despite Q1 Earnings Beat, Gross Margin Contracts
by Zacks Equity Research
ISRG's first-quarter results reflect a healthy demand for procedures on higher system utilization. However, tariffs lead to a decline in the gross margin outlook.
Intuitive Surgical (ISRG) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates
by Zacks Equity Research
Although the revenue and EPS for Intuitive Surgical (ISRG) give a sense of how its business performed in the quarter ended March 2025, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Tesla Q1 Misses on Top & Bottom Lines, Kicks Can on Guidance
by Mark Vickery
Tesla (TSLA) posted its sixth earnings miss in the past seven quarters, coming up -38.6% short.
Intuitive Surgical, Inc. (ISRG) Q1 Earnings and Revenues Beat Estimates
by Zacks Equity Research
Intuitive Surgical (ISRG) delivered earnings and revenue surprises of 5.85% and 3.27%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?
ISRG Q1 Earnings Coming Up: Time to Buy, Sell or Hold the Stock?
by Zacks Equity Research
Intuitive Surgical's first-quarter results are likely to reflect solid performance in the company???s Instruments & Accessories segment. Improving margins buoy optimism.
Is It Worth Investing in Intuitive Surgical (ISRG) Based on Wall Street's Bullish Views?
by Zacks Equity Research
Based on the average brokerage recommendation (ABR), Intuitive Surgical (ISRG) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying?
Intuitive Surgical, Inc. (ISRG) Is a Trending Stock: Facts to Know Before Betting on It
by Zacks Equity Research
Recently, Zacks.com users have been paying close attention to Intuitive Surgical (ISRG). This makes it worthwhile to examine what the stock has in store.
Top Stock Reports for Netflix, SAP & Shell
by Mark Vickery
Today's Research Daily features new research reports on 16 major stocks, including Netflix, Inc. (NFLX), SAP SE (SAP) and Shell plc (SHEL), as well as two micro-cap stocks Preformed Line Products Company (PLPC) and ImmuCell Corporation (ICCC).
Penumbra (PEN) Earnings Expected to Grow: Should You Buy?
by Zacks Equity Research
Penumbra (PEN) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Gear Up for Intuitive Surgical (ISRG) Q1 Earnings: Wall Street Estimates for Key Metrics
by Zacks Equity Research
Looking beyond Wall Street's top -and-bottom-line estimate forecasts for Intuitive Surgical (ISRG), delve into some of its key metrics to gain a deeper insight into the company's potential performance for the quarter ended March 2025.
Intuitive Surgical, Inc. (ISRG) Reports Next Week: Wall Street Expects Earnings Growth
by Zacks Equity Research
Intuitive Surgical (ISRG) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Can ISRG Stock Revive its Growth Momentum After the Sudden Slide?
by Indrajit Bandyopadhyay
Intuitive Surgical has maintained an uptrend since late 2022 with price correcting to 200-DMA a few times and again continuing the uptrend. Will it repeat?
Intuitive Surgical, Inc. (ISRG) Stock Falls Amid Market Uptick: What Investors Need to Know
by Zacks Equity Research
Intuitive Surgical, Inc. (ISRG) concluded the recent trading session at $490.13, signifying a -0.7% move from its prior day's close.
Intuitive Surgical Shares May Rise as FDA Clears SureForm 45 Stapler
by Zacks Equity Research
ISRG secures FDA clearance for the first stapler designed for single-port robotic surgery, advancing minimally invasive procedures and enhancing surgical precision.
Should You Invest in the iShares U.S. Medical Devices ETF (IHI)?
by Zacks Equity Research
Sector ETF report for IHI
Intuitive Surgical (ISRG) Moves 14.3% Higher: Will This Strength Last?
by Zacks Equity Research
Intuitive Surgical (ISRG) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions could translate into further price increase in the near term.